Valuation: IRADIMED CORPORATION

Market Cap 1.31B 1.15B 1.05B 979M 1.86B 125B 1.88B 12.63B 4.91B 61.23B 4.91B 4.8B 212B P/E 2026 *
53.6x
P/E 2027 * 47.3x
Enterprise Value 1.31B 1.15B 1.05B 979M 1.86B 125B 1.88B 12.63B 4.91B 61.23B 4.91B 4.8B 212B EV / Sales 2026 *
14.3x
EV / Sales 2027 * 13x
Free-Float
64.8%
Yield 2026 *
-
Yield 2027 * -
1 day-0.81%
1 week+6.53%
Current month+6.53%
1 month+7.85%
3 months+8.89%
6 months+3.52%
Current year+4.65%
1 week 94.8
Extreme 94.8
102.99
1 month 89.69
Extreme 89.69
102.99
Current year 76.95
Extreme 76.95
107.9
1 year 55.11
Extreme 55.1093
107.9
3 years 36.12
Extreme 36.12
107.9
5 years 26
Extreme 26
107.9
10 years 7.85
Extreme 7.85
107.9
Manager TitleAgeSince
Chief Executive Officer 72 27/05/2020
Director of Finance/CFO 64 19/06/2022
Chief Tech/Sci/R&D Officer - 31/12/2019
Director TitleAgeSince
Chairman 72 15/06/2020
Director/Board Member 70 31/12/2018
Director/Board Member 73 31/12/2013
Date Insider Type Main position Quantity % Market Cap.
06-19Fiscal year

Chief Financial Officer

13,911 0.1088%
06-03Sell

Director

-3,000 0.0235%
05-31Sell

Chief Executive Officer

-2,500 0.0196%
Change 5-day change 1-year change 3-year change Capi.($)
-0.83%+6.53%+72.48%+118.22% 1.31B
+1.73%+4.63%-15.56%-25.12% 12.88B
-7.35%-1.37%+82.27%+7.20% 4.81B
+0.26%+7.10%-30.89%-61.52% 1.24B
-1.20%+3.78%-37.82%-46.83% 1.11B
-1.22%+2.90%-43.88% - 916M
+4.10%-3.10%+177.18%+161.29% 662M
-7.87%-18.60%+47.26% - 330M
-1.87%-11.06%-53.77%+219.66% 257M
-2.38%-2.38%-27.11%-44.03% 141M
Average -1.66%+0.81%+17.02%+41.11% 2.37B
Weighted average by Cap. -0.72%+1.87%+12.04%-4.71%

Financials

2026 *2027 *
Net sales 91.2M 79.87M 73.57M 68.29M 130M 8.7B 131M 881M 343M 4.27B 342M 335M 14.81B 101M 88.37M 81.39M 75.55M 143M 9.62B 145M 974M 379M 4.72B 379M 371M 16.38B
Net income 24.55M 21.5M 19.8M 18.38M 34.91M 2.34B 35.38M 237M 92.26M 1.15B 92.2M 90.17M 3.99B 27.8M 24.35M 22.43M 20.82M 39.53M 2.65B 40.06M 268M 104M 1.3B 104M 102M 4.51B
Net Debt - -
Logo IRADIMED CORPORATION
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories, disposables and services. Its MRidium 3870 MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium 3860+ MRI Compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to safely and predictably and other IV fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably on magnetic fields of over 30,000 gauss.
Employees
166
Date Price Change Volume
07/07/26 US$101.80 -0.49% 15,664
06/07/26 US$102.30 +1.32% 110,886
02/07/26 US$100.97 +2.99% 130,062
01/07/26 US$98.04 +2.60% 154,909
30/06/26 US$95.56 +1.58% 109,602
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
102.30USD
Average target price
118.00USD
Spread / Average Target
+15.35%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRMD Stock